This session will explore and contrast the legal framework for engaging in secondary uses of health information under US privacy law and the GDPR. Session leaders will start with a comparative overview of health privacy and key related laws in the US and Europe, and move on to specific issues and challenges relating to the secondary use of health information under these laws, with a focus on HIPAA, the Common Rule, FDA laws and regulations, and GDPR.
Jiayan Chen, Partner, McDermott Will & Emery
Deepali Doddi, Associate, McDermott Will & Emery
Irina Ridley, Chief Counsel, Myriad Women’s Health